Protocol of the Actifcare (ACcess to Timely Formal Care) study by Kerpershoek, Liselot et al.
STUDY PROTOCOL Open Access
Access to timely formal dementia care in
Europe: protocol of the Actifcare (ACcess to
Timely Formal Care) study
Liselot Kerpershoek1*, Marjolein de Vugt1*, Claire Wolfs1, Hannah Jelley2, Martin Orrel3, Bob Woods2,
Astrid Stephan4, Anja Bieber4, Gabriele Meyer4, Knut Engedal5, Geir Selbaek5, Ron Handels1,6, Anders Wimo6,
Louise Hopper7, Kate Irving7, Maria Marques8, Manuel Gonçalves-Pereira8, Elisa Portolani9, Orazio Zanetti9,
Frans Verhey1 and the Actifcare Consortium
Abstract
Background: Previous findings indicate that people with dementia and their informal carers experience difficulties
accessing and using formal care services due to a mismatch between needs and service use. This mismatch causes
overall dissatisfaction and is a waste of the scarce financial care resources. This article presents the background and
methods of the Actifcare (ACcess to Timely Formal Care) project. This is a European study aiming at best-practice
development in finding timely access to formal care for community-dwelling people with dementia and their
informal carers. There are five main objectives: 1) Explore predisposing and enabling factors associated with the use
of formal care, 2) Explore the association between the use of formal care, needs and quality of life and 3) Compare
these across European countries, 4) Understand the costs and consequences of formal care services utilization in
people with unmet needs, 5) Determine the major costs and quality of life drivers and their relationship with formal
care services across European countries.
Methods: In a longitudinal cohort study conducted in eight European countries approximately 450 people with
dementia and informal carers will be assessed three times in 1 year (baseline, 6 and 12 months). In this year we will
closely monitor the process of finding access to formal care. Data on service use, quality of life and needs will be
collected.
Discussion: The results of Actifcare are expected to reveal best-practices in organizing formal care. Knowledge
about enabling and predisposing factors regarding access to care services, as well as its costs and consequences,
can advance the state of the art in health systems research into pathways to dementia care, in order to benefit
people with dementia and their informal carers.
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Background
Approximately 60 % of persons with dementia live at
home. They have an increased need of care as the dis-
ease progresses. In many countries people with dementia
are encouraged to live at home as long as possible, as it
is assumed that quality of life is better at home than in
institutions and this could also decrease the financial
burden of dementia [1]. Several national and international
organizations such as Alzheimer’s Disease International
(ADI) and Alzheimer Europe, have adopted strategies
to promote timely recognition of dementia (European
Parliament 2011, (http://www.alzheimer-europe.org/).
A timely diagnosis is regarded as necessary to enable
improvements in dementia care. It allows stakeholders
to collaborate in making important decisions regarding
post-diagnostic care. Timely access to dementia care ser-
vices is considered crucial to reduce health care costs e.g.,
to increase the quality of life for patients, to reduce infor-
mal caregiver burden, and by better coordinating nursing
home placement [2]. ‘Timely’ is preferred to ‘early’ in this
context, emphasizing that it is personally tailored and
aimed at reducing both the risk of overtreatment as well
as undertreatment.
Previous findings indicate that people with dementia
and their informal carers experience difficulties acces-
sing and working with community care services, even
when having a diagnosis of dementia [3, 4]. This can put
increasing pressure on them, which might lead to admis-
sion to a residential home simply because the appropri-
ate support is not in place [5]. If such a mismatch
between needs and service use occurs there is overall
dissatisfaction for the service user and a waste of the
scarce financial care resources. In these times where the
financial burden of dementia should be decreased by
encouraging people with dementia to live at home as
long as possible, other efforts to restrain budget are of
interest too. Economic evaluation of formal care service
use is thus a crucial task. Factors that influence the
access to and use of formal care can be explored with
the Behavioural Model of Health Service Use by
Andersen and colleagues [6] (see Fig. 1). This model de-
scribes predisposing and enabling factors in relation to
needs and service use. The main deduction is that before
services are being used, various factors positively influ-
ence patients and their informal carers to use services
(predisposing variables), while other factors enable ser-
vice use (enabling factors), and other variables determine
the need for care (need variables). Predisposing variables
include demographics (age, gender, marital status),
socio-structural variables such as education and ethni-
city, and health beliefs for example about disease and
care. Enabling factors are resources either supporting or
impeding service use (waiting lists, health insurance
coverage). Need variables consist of the impairments
that require service, e.g. type of illness. The relation be-
tween these variables is complex, and could change dur-
ing the progress of dementia, as needs are constantly
changing [7].
Figure 1: Andersen Behavioural Model of Health
Service Use [8].
The Andersen model can be used to understand access
to and use of services by identifying associations be-
tween service use and a broad spectrum of predisposing
and enabling variables, while controlling for need. The
differences between countries regarding equity in which
services are accessed and delivered have not yet been
studied, despite the critical nature of this information
for understanding the current health care systems. Well-
organized access to formal care is especially important
in the middle stage of dementia, as increased care is
needed in this stage.
The Actifcare (Access to timely formal care) study fo-
cuses on this middle stage of dementia, which makes it
innovative in contrast to previous dementia studies that
have focused predominantly on early or later stages.
Actifcare builds on a previous European Commission
Fig. 1 Andersen Behavioural Model of Health Services Use. Graphic representation of the model [6]
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Framework Programme project called Right Time Place
Care (RTCP) [9] and focuses on people who are not
using formal care, but are most likely to start in the near
future. This enables a specific evaluation of the process
of accessing formal care.
This protocol focuses on the part of the Actifcare
study that aims to increase our understanding of why
people with dementia and their informal carers use, or
fail to use formal care services across Europe, and how
the use of formal care is experienced. In Actifcare formal
care includes home nursing care, day care service, com-
munity or long-term medical care, nursing and social
care structures. It excludes domestic home help, house-
keepers, volunteers, support groups, transport services
and meal programs. The present state of the art con-
cerning access to timely formal care for people with de-
mentia and their informal carers will be envisioned. We
want to explore the reasons behind (non)-use of formal
care by learning from experiences of people with demen-
tia and their informal carers. Through different methods
of data collection we aim to identify best-practice strat-
egies regarding access to formal care for this vulnerable
group. We will also use our large international database
to validate some new measures during this study. Know-
ledge about enabling and predisposing factors regarding
access to care services as well as its costs and conse-
quences can advance the state of the art in health sys-
tems research into pathways to dementia care, in order
to benefit people with dementia and their informal
carers.
The main objectives are the following:
1) Exploring the predisposing and enabling factors that
are associated with the use of formal care services;
2) Exploring the association between the use of formal
care, needs and quality of life in people with dementia
and their informal carers;
3) Comparing these across different European countries;
4) Understanding the costs and consequences of formal
care services utilization in people with unmet needs
in Europe;
5) Determining the major costs and quality of life
drivers and the relation with formal care services
across European countries;
6) Validation of the relatively new ICECAP-O instrument
and the CarerQol instrument for the assessment of
quality of life in relation to the timing of formal care in
Europe.
Methods/Design
Overall methodology
To achieve these objectives a longitudinal cohort of pa-
tients will be recruited in eight countries. Themes, which
are obtained in focus groups and expert interviews
preceding this longitudinal study, will form the basis for
in-depth semi-structured interviews.
Design
A prospective cohort study design is adopted and is
conducted in eight European countries (Germany,
Netherlands, Sweden, Norway, Ireland, United Kingdom,
Portugal and Italy). Baseline assessments started in
November 2014 and follow-up measurements are
planned after 6 and 12 months. Last patient out is ex-
pected in June 2016.
Participants
The study aims to assess 480 dyads (60 per country)
representing a cohort of community-dwelling people
with dementia and their informal carers. Due to the
exploratory nature of this study no power calculation
is necessary. Eligibility criteria are described in
Table 1. Participation is restricted to mentally compe-
tent people with dementia. Only people with demen-
tia and their carers who provided informed consent
participate. The carer and the person with dementia
Table 1 Eligibility criteria for dyad selection
- The patient has a diagnosis of dementia meeting DSM IV TR criteria
following an assessment by a clinical professional.
- The person with dementia has a Clinical Dementia Rating indicating
mild or moderate degree of dementia (i.e. scores 1 or 2) or scores 24
or less on the MMSE.
- The patient is not receiving regular assistance from a paid worker with
personal care, on account of his/her dementia, such as help with
dressing/undressing; washing/ bathing/ showering; toileting; feeding/
drinking; taking medication. (Note: ‘regular’ is defined as at least once
per week; ‘paid worker’ includes those paid by health and social care
services and those paid direct by the person and his/her family).
- A professional judges that additional assistance with personal care is
likely to be considered/required within 1 year.
- The person with dementia has a carer who is able and willing to
participate and is in contact at least once per week. The carer does
not have to be residing with the carer, they could be a relative, friend
or neighbour in regular contact.
Exclusion criteria
- The person with dementia or their carer is not able to complete the
assessments due to communication/language/hearing/understanding/
literacy problems that cannot be compensated for.
- The person with dementia or their carer has a terminal condition
or comorbidities (including long-standing severe mental illness)
contributing to a significant level of disability
- The person with dementia or their carer has a life-long learning
disability or severe physical impairment that would prevent them
from being able to complete the assessments.
- The person with dementia resides in a care home or nursing home
or has been resident in a care home or nursing home (e.g. for respite)
during the previous 6 months.
- The person with dementia has a diagnosis of alcohol-related
dementia or of Huntington’s disease.
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both sigh a separate informed consent form, after
they had sufficient time to read the form and ask
questions if needed. Participants are recruited from
various settings, e.g. general practices, memory clinics,
casemanagers and community mental health teams. In
addition advertisements are placed in local and vari-
ous national newspapers.
Measures
Table 2 summarizes the outcome measures, which were
selected through careful consideration of psychometric
properties and clinical utility. Questionnaires that were
not available in all languages were translated and back
translated via a translation protocol to ensure validity.
Main outcomes
One of the main objectives in Actifcare concerns met
and unmet needs. These will be assessed with the
Camberwell Assessment of Need for the Elderly
(CANE), a tool especially designed to combine opinions
regarding needs from people with dementia, informal
carers and professionals [10]. The Resource Utilisation
in Dementia instrument (RUD) measures service use,
and will be completed by the researcher based on infor-
mation provided by the carer. With the RUD we can
obtain information regarding medical resources and in-
formal care resource use [11]. A service use checklist
was constructed with input from all participating coun-
tries to provide more information on the (non)-use of
services and the reasons behind this.
Measures for people with dementia
Measures for people with dementia include a range of
quality of life scales. The Quality of Life- Alzheimer’s
Disease scale (QOL-AD) is a reliable and valid scale
for people with dementia with a Mini Mental State
Examination (MMSE) score above 10 [12]; the same
accounts for the DEMQOL. Both the QOL-AD and
DEMQOL have a proxy-report version as well [13].
The ICECAP-O is a generic instrument that measures
capabilities with preference-based tariffs applicable in
health-economic evaluation. This promising tool is
expected to more sensitively capture changes resulting
from the use of formal care services in the middle
stage of dementia than the EuroQol [14]. Health-
related quality of life scales will also be administered.
The EuroQol-5D has been validated in a number of
European countries in and in the dementia popula-
tion. It consists of five items and a people with mild
to moderate dementia and it assesses the subjective
perceptions and experiences of people with dementia
[13]. In addition cognitive functioning is assessed with
the Mini Mental State Examination (MMSE) [15], and
the quality of the relationship with the informal carer
with the Positive Affect Index (PAI) [16].
Measures for the informal carers
There are several measures for the informal carer re-
garding quality of life (EQ-5D-5L, CarerQol, ICECAP-O).
The Care related quality of life scale (CarerQol) was devel-
oped (along the lines of the EuroQol instrument) to meas-
ure the impact of informal care by assessing happiness
and describing the most important burden dimensions.
This promising instrument will be applied and validated
in the participating European countries [17, 18]. Anxiety
and depression will be measured with the 14 item
Table 2 Measurement instruments
Measurement instruments
Variable Measure Assessed by
People with dementia
Socio-demographics Datasheeta PwD
Cognition MMSE PwD
Service use Checklist PwD/CG
Personal and social resources RUD CG
Health-related quality of life EQ-5D-5L PwD
Quality of life of PwD DEMQOL-U PwD
DEMQOL-U-Proxy CG
QOL-AD PwD, CG
EQ-5D-5L CG
Quality of relationship PAI PwD
Capability ICECAP-O PwD
(un)met needs CANE PwD, CG, In
Neuropsychiatric symptoms NPI-Q CG
Severity of dementia CDR In
Comorbidity Charlson Index In
Activities of daily life IADL CG
PSMS CG
Informal carers
Social isolation LSNS-6 CG
Quality of relationship PAI CG
Quality of life CarerQol-7D CG
Health related quality of life EQ-5D-5L CG
Anxiety and depression HADS CG
Perseverance time Single question CG
Stress RSS CG
Capability ICECAP-O CG
Control Locus of controla CG
Sense of coherence SOC-13 CG
Personal and social resources RUD CG
Pwd people with dementia, CG informal carers, In interviewer. Measures which
are only assessed at baseline are marked with an a
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Hamilton Anxiety and Depression Scale (HADS) [19].
Perseverance time is measured with a single simple esti-
mate of how long the informal carer can continue in this
way if the situation remains unchanged. In addition,
caregiving-related stress and social network is assessed
with the Relative Stress Scale (RSS) [20] and the Lubben
social network scale (LSNS-6) [21]. These measures are
important as they give us a broad insight on different as-
pects of life of the informal carer. Information regarding
internal and external locus of control (Locus of Control of
Behaviour Scale) and sense of coherence are also assessed
(SOC-13) [22, 23].
The carer will also provide information regarding
the persons’ with dementia functional abilities. The
Instrumental Activities of Daily living (IADL) scale pro-
vides us with specific information on daily living skills
while the Physical Self-Maintenance Scale (PSMS) gives
information about physical abilities [24]. Neuropsychiatric
symptoms are assessed with the Neuropsychiatric
Inventory (NPI-Q), as these influence caregiver burden
[25]. Quality of life will be assessed with several measures
similar to those administered with the people with
dementia (QOL-AD, EQ-5D-5L, ICECAP-O) along
with the DEMQOL-U proxy which is specifically de-
signed for carers to rate quality of life for the people
with dementia [13].
Additional measures
Comorbidities will be assessed with the Charlson
Comorbidity Index, to control for service use for causes
other than dementia [26]. Severity of dementia will be
assessed with the Clinical Dementia Rating (CDR) [27].
People with dementia and carers will also complete a
short questionnaire on socio-demographic information
(age, gender, ethnicity, education, occupation, living
situation).
Procedures cohort study
At baseline, at 6 months follow-up and at 12-months
follow-up all questionnaires will be administered in the
hospital or at home to ensure that participants are in a
comfortable environment. The visit can be shortened or
split in two to reduce the burden for the participants.
All researchers involved have been trained in administer-
ing the different questionnaires and have clinical experi-
ence. In a purposively sampled subgroup of n = 10 per
country, in-depth semi-structured interviews will be
conducted at 12-months follow-up ensuring inclusion of
both dyads using formal care services and dyads not
using formal care services. The content of the interview
is developed from the outcome of a literature review and
focus groups. Themes that will be discussed are e.g. atti-
tude towards dementia, cooperation with healthcare pro-
fessionals, joint decision making of the informal carer
and the person with dementia regarding service use. The
interviews will be tape-recorded and transcribed verba-
tim for analysis. Data triangulation through verification
by two researchers will be used to ensure the trust-
worthiness of the data analysis.
Statistical analyses
Group characteristics per individual country will be cal-
culated with proportions or means. Group comparisons
will be performed with Chi square tests for categorical
variables and t-tests for continuous variables. Transcul-
tural differences are a specific area of interest. To ensure
valid comparison of service use among countries direct
standardizations will be carried out (using the entire
pooled sample as the external standard population) for
the effects of age group, gender, educational level, de-
mentia diagnosis and severity. The relationship between
predisposing factors, enabling factors and use of formal
care services will be explored with a multi-level analysis.
Cross level effect modification (e.g. living in a specific
country/country cluster modifies the effect of individual
characteristics on service use) will be examined to iden-
tify ecological effects. To assess the potential inequity
with which services are accessed and delivered, the associ-
ations between service use and predisposing and enabling
variables will be controlled for needs. Multiple regression
analysis will be used to explore the relationship between
service use, met and unmet needs (independent variables)
and quality of life of the people with dementia and infor-
mal carer (dependent variables).
Discussion
The current study focuses on middle stage dementia,
and explores the association between the use of formal
care, needs and quality of life in people with dementia
and their informal carers in eight European countries.
This paper describes the research protocol of the cohort
study. The Actifcare projects aims to increase our un-
derstanding of why people with dementia and their in-
formal carers use, or fail to use formal care services
across Europe, and how the use of formal care is
experienced.
The strengths of this cohort study are the overall size,
where patient inclusion in different countries enables
cross-country comparison. The fact that participants are
included across different parts of Europe ensures diver-
sity in the group, which enables us to investigate con-
textual differences. Measurements are assessed at three
different time points; in this way we can follow patients
and their carers throughout the trajectory in which for-
mal care is initiated. One of the potential limitations is
selection bias; those people who refuse service use are
not likely to take part in a study concerning needs and
service use, as they refuse all types of interference. It
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would be interesting to hear the rationale behind deci-
sions from these people with dementia.
With the input of people with dementia, their informal
carers and professionals we can develop formal care
strategies, and combine these with information on cost-
efficiency across Europe. This information will help us
develop best-practice strategies to improve effectiveness
and efficiency of access to European dementia care sys-
tems. We will reach a consensus regarding recommen-
dations across countries, and create country-specific
recommendations for the implementation of best prac-
tice strategies. Once the project ends and recommenda-
tions are developed, we will disseminate these results to
a wide audience through different methods. The target
audience is health care professionals, national health ser-
vices, the general public, patient advocacy groups and
dementia researchers. A Consortium and Advisory board
of expertise has been set up, representing different
professional disciplines; several representatives of the
project are closely related to national political boards as
well as to institutions and political boards of the
European Union. This will additionally facilitate wide-
spread dissemination of results. The results will be avail-
able after the end of the cohort study in June 2016.
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